IMPRINT is a network focusing on maternal and neonatal immunization, funded by the UK’s Global Challenges Research Fund (GCRF) which supports challenge-led interdisciplinary research and aims to strengthen capacity for research and innovation within the UK and in developing countries. IMPRINT is coordinated by Network Director Prof. Beate Kampmann (London School of Hygiene and Tropical Medicine) and Co-Director Dr. Chrissie Jones (University of Southampton).
IMPRINT brings together people working with PASSION
IMPRINT aims to build a sustainable network of stakeholders from basic science, immunology, vaccinology, social sciences, industry, public health and national and international policy makers, to tackle the challenges in the best use of vaccines in pregnancy and in newborns, and in the long term to improve maternal and newborn health. With nearly 300 members from 50 countries that all share the same passion for maternal immunization, IMPRINT has quickly become a highly productive, multi-disciplinary and innovative network that is ready to make an impact.
The IMPRINT network has developed a survey for monitoring how immunisation efforts for pregnant women, newborns and infants are impacted by the COVID-19 pandemic.
The American Journal of Obstetrics & Gynecology MFM has published a series of articles on COVID-19 and pregnancy.
Our board member Sonali Kochhar wrote an article on clinical trials during outbreaks that includes ethical considerations for the inclusion of pregnant women in vaccine trials.